Has Tiffany Harkleroad, NP received payments from drug or device companies?

Yes. Drug and device makers reported $16,304 in general payments to Tiffany Harkleroad, NP across 554 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tiffany Harkleroad, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tiffany Harkleroad, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tiffany Harkleroad, NP

Family · Waycross, GANPI 1174172142

Payments from drug & device makers

$16,304in general payments, 2019–2025

Across 554 payments — averaging $29.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$1K
Pharmacosmos Therapeutics Inc.$1K
AstraZeneca$1K
Pfizer$944
Seagen Inc.$838
Johnson & Johnson$820
plus $10K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	42	$1,194
Pharmacosmos Therapeutics Inc.	16	$1,106
AstraZeneca(2 entities)	42	$1,012
Pfizer	30	$944
Seagen Inc.	19	$838
Johnson & Johnson	26	$820
Novartis	48	$791
E.r. Squibb & Sons, L.L.C.	26	$676
Gilead(2 entities)	14	$608
Astellas Pharma US Inc	17	$587
GSK	13	$473
AbbVie	14	$464
Daiichi Sankyo Inc.	17	$432
Takeda Pharmaceuticals U.S.A., Inc.	8	$409
Sobi, Inc	12	$382
Bristol Myers Squibb	15	$377
Genentech, Inc.	3	$358
Incyte Corporation	8	$276
Amgen	16	$259
ADC Therapeutics America, Inc.	6	$230
Tempus AI, Inc	6	$219
Sanofi	10	$208
Novocure Inc.	5	$196
G1 Therapeutics, Inc.	7	$196
Lilly USA, LLC	7	$193
Exelixis Inc.	10	$188
Adaptive Biotechnologies Corporation	4	$171
Paratek Pharmaceuticals, Inc.	3	$166
Eisai Inc.	8	$164
Genentech USA, Inc.	9	$157
Jazz Pharmaceuticals Inc.	2	$153
Octapharma USA, Inc.	6	$137
Rigel Pharmaceuticals, Inc.	3	$130
Bayer	2	$112
Taiho Oncology, Inc.	6	$110
Boehringer Ingelheim	5	$110
Alkermes, Inc.	1	$100
Servier Pharmaceuticals LLC	6	$100
Immunocore Limited	4	$92
Sumitomo Pharma America, Inc.	4	$89
Regeneron Healthcare Solutions, Inc.	5	$85
Pharmaessentia USA Corporation	4	$78
Beone Medicines USA, Inc.	3	$73
Tersera Therapeutics LLC	3	$69
Pharmacyclics LLC, An Abbvie Company	2	$65
Morphosys, US Inc.	4	$64
Myovant Sciences Inc.	3	$62
Fennec Pharmaceuticals, Inc.	4	$62
Deciphera Pharmaceuticals Inc.	3	$61
Puma Biotechnology, Inc.	3	$59
Array Biopharma Inc	4	$56
Mirati Therapeutics, Inc.	2	$46
Karyopharm Therapeutics Inc.	1	$45
EUSA Pharma (US) LLC	2	$39
EMD Serono, Inc.	1	$31
Geron Corporation	2	$29
Recordati_rare_diseases_inc.	1	$28
Coherus Oncology, Inc.	1	$26
Foundation Medicine, Inc.	1	$21
Beigene USA, Inc.	1	$20

How this compares

$16,304 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Medicare billing

Part B allowed, 2024

$5,951

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Waycross

Hannah BanachWaycross$85K
Morgan EldridgeWaycross$15K
Allie McAllisterMarietta$299K
Tonita WashingtonLawrenceville$153K
Erin HenryLawrenceville$135K
Trisha RomanPeachtree City$134K
Lori ReedMarietta$106K
Julia BranchCumming$102K
Morgan GroothandEvans$81K
Anna Carolina WrightLilburn$69K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →